On September 30, 2015, Siegfried closed the acquisition of BASF’s pharmaceutical supply business and the corresponding three sites in Evionnaz (CH), Saint-Vulbas (FR) and Minden (DE). The debt-free price of the acquisition amounts to approximately EUR 270 million. The acquisition was funded by, among others, a syndicated multicurrency credit facilities agreement, a privately placed hybrid convertible bond of Siegfried Holding AG in the amount of CHF 60 million, and a public hybrid bond in the amount of CHF 100 million to be listed on SIX Swiss Exchange, which was priced on October 2, 2015, and will be issued on October 26, 2015.

On the financing of this acquisition Siegfried Holding AG was advised as to Swiss law by Homburger. The Homburger team was led by partner Jürg Frick (Financial Services), comprised partners Heinz Schärer (Corporate | M&A), Dieter Grünblatt (Tax) and Stefan Oesterhelt (Tax) and associate Benjamin Leisinger (Financial Services).